Relay Therapeutics, Inc.
RLAY
$3.20
-$0.06-1.84%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 8.97% | -34.03% | 6.39% | 13.64% | -23.69% |
| Total Depreciation and Amortization | -2.98% | 0.29% | 2.55% | 16.54% | 17.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.47% | 8.71% | -36.16% | 17.26% | 368.52% |
| Change in Net Operating Assets | 107.03% | 73.42% | 35.03% | 7.61% | -423.38% |
| Cash from Operations | 35.12% | 0.42% | 4.03% | 25.04% | -56.25% |
| Capital Expenditure | 100.00% | 61.53% | 99.27% | 7.05% | 94.91% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -51.51% | -275.02% | -13.68% | -84.06% | 141.35% |
| Cash from Investing | -51.41% | -276.78% | -11.17% | -86.02% | 140.61% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -96.35% | 2,214.33% | -25.87% | 3,671.94% | 1,779.76% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -96.35% | 2,214.33% | -25.87% | 3,671.94% | 1,779.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -269.73% | 225.18% | -22.94% | -3.70% | 96.26% |